This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignees: Cornell University, Yale University. Active years: 2024.
Company Filing History:


Years Active: 2024
Title: Innovations by Jonas Malmsten
Introduction
Jonas Malmsten is an accomplished inventor based in Gibsonton, Florida. He has made significant contributions to the field of reproductive technology, particularly in the classification of artificially fertilized embryos. His innovative approach combines advanced imaging techniques with artificial intelligence to enhance the success rates of embryo implantation.
Latest Patents
Malmsten holds a patent for a "System and method for selecting artificially fertilized embryos." This method involves obtaining images of a set of artificially fertilized embryos incubating in an incubator. The morphological quality of these embryos is assessed using a convolutional neural network trained on pre-classified embryo images. Each embryo is graded based on its morphological quality, and a probability of successful pregnancy is computed for each embryo. The method ultimately recommends one or more embryos for implantation based on the likelihood of a successful pregnancy.
Career Highlights
Throughout his career, Jonas Malmsten has worked with prestigious institutions such as Cornell University and Yale University. His work has focused on improving reproductive outcomes through innovative technologies and methodologies. His research has garnered attention for its potential to revolutionize the field of assisted reproductive technology.
Collaborations
Malmsten has collaborated with notable professionals in his field, including Nikica Zaninovic and Olivier Elemento. These collaborations have contributed to the advancement of research in embryo selection and reproductive health.
Conclusion
Jonas Malmsten's contributions to the field of reproductive technology through his innovative patent demonstrate his commitment to improving the chances of successful pregnancies. His work continues to influence the landscape of assisted reproductive technology.